Patents by Inventor Januario E. Castro

Januario E. Castro has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-cancer polyketide compounds
    Patent number: 9604973
    Abstract: Provided herein, inter alia, are anticancer polyketides. The uses of the polyketides described herein include treatment of cancer, for example, through regulation of the spliceosome and detection of spliceosome inhibition.
    Type: Grant
    Filed: September 26, 2014
    Date of Patent: March 28, 2017
    Assignee: The Regents of the University of California
    Inventors: Michael D. Burkart, James J. La Clair, Brian D. Jones, Alexander Mandel, Reymundo Villa, Januario E. Castro, Manoj Kumar Kashyap, Deepak Kumar
  • ANTI-CANCER POLYKETIDE COMPOUNDS
    Publication number: 20150133535
    Abstract: Provided herein, inter alia, are anticancer polyketides. The uses of the polyketides described herein include treatment of cancer, for example, through regulation of the spliceosome and detection of spliceosome inhibition.
    Type: Application
    Filed: September 26, 2014
    Publication date: May 14, 2015
    Inventors: Michael D. Burkart, James J. La Clair, Brian D. Jones, Alexander Mandel, Reymundo Villa, Januario E. Castro, Manoj Kumar Kashyap, Deepak Kumar
  • Methods of detecting chronic lymphocytic leukemia with Hsp90 and ZAP-70
    Patent number: 8741578
    Abstract: Provided are compositions and methods useful for treating and diagnosing cell proliferative disorders associated with Hsp90 and/or ZAP-70.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: June 3, 2014
    Assignee: The Regents of the University of California
    Inventors: Januario E. Castro, Thomas J. Kipps, Carlos E. Prada
  • Methods and Compositions for Treating Chronic Lymphocytic Leukemia
    Publication number: 20080280878
    Abstract: Novel method of treating chronic lymphocytic leukemia by the administering of HSP90 inhibitors, particularly ansamycins, more particularly I 7-allylamino-I 7-demethoxygetdanarnycin (17-AAG).
    Type: Application
    Filed: November 2, 2005
    Publication date: November 13, 2008
    Inventors: Januario E. Castro, Thomas J. Kipps, Francis J. Burrows, Adeela Kamal, Carlos E. Prada